Am I eligible for a clinical trial if I have HER2-Positive Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Clinical Trial Eligibility with HER2-Positive Breast Cancer
Yes, you may be eligible for clinical trials—and this is an important option to explore. According to the NCCN Guidelines, everyone with cancer should carefully consider all treatment options available, including both standard treatments and clinical trials.
How Eligibility Works
Clinical trials have specific rules called eligibility criteria that determine who can participate. These rules typically consider:
- Your cancer type and stage (HER2-positive breast cancer is a specific category that many trials target)
- Your age and overall health
- Previous treatments you've received (how many "lines" of therapy you've had)
- Any other medical conditions you have (called comorbidities)
- Your current disease status (whether cancer is progressing, stable, or responding)
- Specific genetic or biomarker findings (like your HER2 status)
Why HER2-Positive Status Matters for Trials
Your HER2-positive status is actually valuable for clinical trial matching. Many trials specifically target HER2-positive breast cancers because researchers understand how this protein drives cancer growth. This means there are likely trials designed specifically for patients like you.
Important Points About Clinical Trials
You should know:
- Placebos (inactive treatments) are almost never used alone in cancer clinical trials—you'll typically receive either a new drug combined with standard treatment, or a new approach compared to standard treatment
- There is no fee to enroll in a clinical trial—the study sponsor pays for research-related costs, including the study drug
- You can leave a clinical trial at any time and seek other treatment
- You'll continue to receive standard cancer care during the trial, which is usually covered by insurance
Next Steps: Questions to Ask Your Oncologist
According to NCCN Guidelines, don't wait for your doctor to bring up clinical trials—start the conversation yourself:
- "What clinical trials are available for my HER2-positive breast cancer?"
- "How do I find out if I meet the eligibility requirements?"
- "What are the specific treatments being tested in trials you'd recommend for me?"
- "How will you know if the treatment is working?"
- "If this trial doesn't work for me, what other treatment options would be available?"
Where to Find Clinical Trials
- NCCN Cancer Centers: nccn.org/cancercenters
- National Cancer Institute (NCI): cancer.gov/about-cancer/treatment/clinical-trials/search
- Ask your oncology team directly about trials they know about
The key is to have an open conversation with your healthcare team about whether a clinical trial might be right for your specific situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for HER2-Positive Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: